U.S. markets close in 1 hour 24 minutes
  • S&P 500

    3,829.97
    -40.32 (-1.04%)
     
  • Dow 30

    31,356.45
    -35.07 (-0.11%)
     
  • Nasdaq

    13,012.83
    -345.95 (-2.59%)
     
  • Russell 2000

    2,221.63
    -9.88 (-0.44%)
     
  • Crude Oil

    61.21
    +1.46 (+2.44%)
     
  • Gold

    1,713.00
    -20.60 (-1.19%)
     
  • Silver

    26.26
    -0.62 (-2.30%)
     
  • EUR/USD

    1.2070
    -0.0018 (-0.14%)
     
  • 10-Yr Bond

    1.4690
    +0.0540 (+3.82%)
     
  • GBP/USD

    1.3956
    -0.0001 (-0.01%)
     
  • USD/JPY

    106.9800
    +0.2700 (+0.25%)
     
  • BTC-USD

    50,468.93
    +2,587.34 (+5.40%)
     
  • CMC Crypto 200

    1,010.84
    +22.75 (+2.30%)
     
  • FTSE 100

    6,675.47
    +61.72 (+0.93%)
     
  • Nikkei 225

    29,559.10
    +150.93 (+0.51%)
     

Pacific Biosciences (PACB) Looks Good: Stock Adds 5.3% in Session

  • Oops!
    Something went wrong.
    Please try again later.
Zacks Equity Research
·2 min read
  • Oops!
    Something went wrong.
    Please try again later.

Pacific Biosciences of California, Inc. PACB was a big mover last session, as the company saw its shares rise more than 5% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company—as the stock is now up 34.2% in the past one-month time frame.

The company has seen two positive estimate revisions in the past few months, while its Zacks Consensus Estimate for the current quarter has also moved higher over the past few months, suggesting that more solid trading could be ahead for Pacific Biosciences. So, make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.

Pacific Biosciences currently has a Zacks Rank #2 (Buy) while its Earnings ESP is positive.

Pacific Biosciences of California, Inc. Price

Pacific Biosciences of California, Inc. Price
Pacific Biosciences of California, Inc. Price

Pacific Biosciences of California, Inc. price | Pacific Biosciences of California, Inc. Quote

Another stock worth considering in the Medical - Instruments industry is Hologic, Inc. HOLX which carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

5 Stocks Set to Double

Each was hand-picked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2020. Each comes from a different sector and has unique qualities and catalysts that could fuel exceptional growth.

Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.

Today, See These 5 Potential Home Runs >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Hologic, Inc. (HOLX) : Free Stock Analysis Report
 
Pacific Biosciences of California, Inc. (PACB) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research